| Market Cap | ₹11,019Cr | 
| ROE | 42.11% | 
| P/E Ratio(TTM) | 27.81 | 
| EPS(TTM) | 172.04 | 
| P/B Ratio | 12.80 | 
| Dividend Yield | 2.44% | 
| Industry P/E | 34.63 | 
| Book Value | 373.70 | 
| Debt to Equity | 0.02 | 
| Face Value | 10 | 
| Parent Organisation | Sanofi India Limited | 
| Managing Director | Mr. Rodolfo Hrosz | 
| NSE Symbol | SANOFI | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Abbott India | NA (0.00%)  | 42.56  | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%)  | 47.88  | ||
| Astrazeneca Pharma India | NA (0.00%)  | 133.86  | ||
| Pfizer | NA (0.00%)  | 29.29  |